Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT07595302
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pelvic Pain
Eligibility Criteria
- Sex
- FEMALE
- Age
- 16 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Acetaminophen 1000mg PO — DRUGOral Acetaminophen 1000mg
- IV Acetaminophen 1000mg — DRUGIntravenous Acetaminophen 1000mg
- IV Placebo — OTHERIV placebo administration
- PO Placebo — OTHEROral placebo administration
Study Details
The investigator team proposes a randomized, double-blind, double-dummy comparative effectiveness trial conducted in two urban emergency departments (EDs) in the Bronx, New York. This study is designed to determine the relative efficacy of IV acetaminophen compared to PO acetaminophen in treating pelvic pain. This design focuses on the early onset of action and short-term efficacy, which may better capture potential differences between IV and PO acetaminophen in the acute ED setting.
Key Dates
- Start date
- Jul 30, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 140 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Oral Drug + IV PlaceboOral Acetaminophen 1000mg + IV placebo Oral Acetaminophen 1000mg No additional analgesics will be administered prior to two hours unless clinically indicated. Rescue analgesia may be administered at any time at the discretion of the treating clinician.
- Active Comparator: Intravenous Drug + Oral PlaceboIntravenous Acetaminophen + PO placebo IV Acetaminophen 1000mg No additional analgesics will be administered prior to two hours unless clinically indicated. Rescue analgesia may be administered at any time at the discretion of the treating clinician.
Primary Outcome Measure
Mean Change in Numeric Rating Scale (NRS) score [ Time Frame: From baseline to 30 minutes following medication administration ]
Central Contacts
- Mustfa Manzur, MD MPH MS718-920-6674
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 | Eddie M Irizarry, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in The Bronx, NY
Related Studies
- Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic VaricesRecruiting · Weill Medical College of Cornell University · New York, New York
- Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain ReliefNot Yet Recruiting · Weill Medical College of Cornell University · New York, New York
- Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsNot Yet Recruiting · R3 Stem Cell · Encino, California
- Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein EmbolizationRecruiting · University of Kansas Medical Center · Kansas City, Kansas